CILcare will present a valuable diagnostic tool to assess the tolerance of otic products in pets at the 32nd ESVD Congress

CILcare’s team is pleased to announce that the abstract co-written with Virbac, a top 10 animal health company, entitled “Ear inflammation and hearing measurements: taking advantage of preclinical tools to…

Continue ReadingCILcare will present a valuable diagnostic tool to assess the tolerance of otic products in pets at the 32nd ESVD Congress

BIO Korea 2021 Replay : Noise-induced hearing loss and ageing : physiopathology & strategies for preclinical development

Do you want to learn more on noise-induced hearing loss and ageing? Which strategies can you choose for a successful preclinical development? Find out by watching this presentation given by…

Continue ReadingBIO Korea 2021 Replay : Noise-induced hearing loss and ageing : physiopathology & strategies for preclinical development

CILcare and Knotus partner to accelerate the development of novel therapies to prevent and treat ear disorders in Korean and Asian market

Montpellier & Seoul, June 8th, 2021: CILcare, the world’s leading CRO dedicated to ear disorders, and Knotus, a leading Korean non-clinical CRO, announced today that they have entered into a strategic partnership that…

Continue ReadingCILcare and Knotus partner to accelerate the development of novel therapies to prevent and treat ear disorders in Korean and Asian market